Sinovac Life Sciences Co., Ltd.

This study tests a new vaccine (PCV13) to protect healthy infants from pneumococcal infections, which can cause pneumonia, meningitis, and ear infections. About 500 babies aged around 2 months will receive either the new vaccine or an existing one to compare safety and immune res…

This early-stage trial tests a new vaccine designed to protect against several types of meningococcal bacteria that cause meningitis. About 150 healthy volunteers aged 2 to 59 will receive the vaccine or a placebo to check its safety and how well it triggers an immune response. T…